Bloomberg Law
June 19, 2020, 9:49 AM

Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry

Valerie Bauman
Valerie Bauman

Generic drugmakers are increasingly lining up to bring competing versions of brand-name products to the market at the earliest possible date.

But that might be bad for consumers.

It’s no longer just one company seeking to be the first to bring a generic to the market—a status that affords drugmakers 180 days of market exclusivity. Instead, multiple companies are simultaneously seeking and sharing that first-filer status, spurring more litigation for brand-name drugmakers that must then defend their patents.

The trend is growing as the pharmaceutical industry faces increased government pressure over drug pricing and transparency. It raises concerns over whether ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.